Literature DB >> 7935663

Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV.

R Bayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7935663     DOI： 10.1056/NEJM199411033311811

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.

Authors:  Caitlin M Dugdale; Andrea L Ciaranello; Linda-Gail Bekker; Madeline E Stern; Landon Myer; Robin Wood; Paul E Sax; Elaine J Abrams; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Ann Intern Med       Date:  2019-04-02       Impact factor: 25.391

2.  Voluntary newborn HIV-1 antibody testing: a successful model program for the identification of HIV-1-seropositive infants.

Authors:  E J Abrams; D A Bateman
Journal:  Bull N Y Acad Med       Date:  1995

Review 3.  A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.

Authors:  M L Newell; D M Gibb
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 4.  Prevention of maternal HIV transmission. Practical guidelines.

Authors:  C Rouzioux
Journal:  Drugs       Date:  1995       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.